[Congressional Record (Bound Edition), Volume 153 (2007), Part 17]
[Extensions of Remarks]
[Pages 23636-23637]
[From the U.S. Government Publishing Office, www.gpo.gov]




 COMMENDING DR. GARRY A. NEIL, 2007 DISCOVERY AWARDEE FOR THE AMERICAN 
                           GERIATRICS SOCIETY

                                 ______
                                 

                           HON. SCOTT GARRETT

                             of new jersey

                    in the house of representatives

                      Wednesday, September 5, 2007

  Mr. GARRETT of New Jersey. Madam Speaker, I rise today to commend Dr. 
Garry A. Neil, group president of Johnson & Johnson Pharmaceutical 
Research & Development, for his extraordinary contributions to 
advancing the health and well-being of American seniors.
  Dr. Neil has had a long and distinguished career in medical research. 
After graduating from the University of Saskatchewan College of 
Medicine, he performed his post-graduate training in internal medicine 
and gastroenterology at the University of Toronto and performed a 
postdoctoral fellowship in immunology at the Research Institute of 
Scripps Clinic.

[[Page 23637]]

  Prior to joining Johnson & Johnson in 2002, he worked as Vice 
President of Clinical Research for AstraZeneca, Vice President for 
Medical and Scientific Affairs at AstraPharmaceuticals, Director of 
Clinical Research for Gastroenterology and Executive Director for 
Medical Sciences at Astra Merck, and Vice President and global head of 
clinical research and development with Merck KGaA and its U.S. 
subsidiary EMD Pharmaceuticals.
  Since coming to Johnson & Johnson, Dr. Neil has worked in several 
roles to help develop their research program. In fact, he played a 
substantial role in development of INVEGA, a new medicine for 
schizophrenia approved in December 2006, as well as many other 
important drugs. He also a member of the Board of the J&J Development 
Corporation and Vice Chair of the Pharmaceutical Research and 
Manufacturers Association (PhRMA) Science and Regulatory Committee, as 
well as a member of the PhRMA Foundation Board.
  Dr. Neil also has a distinguished career in medical academia, 
currently serving as a member of the Board of Trustees for the 
University of Medicine and Dentistry of New Jersey. He has held a 
number of academic posts at the Ludwig Institute for Cancer Research in 
Toronto, the University of Iowa College of Medicine, and the University 
of Pennsylvania. Furthermore, he has written more than 50 scholarly 
articles and book chapters.
  On October 17th, at the 2007 Lifetime of Caring Gala, the American 
Geriatrics Society will present Dr. Neil with the 2007 Discovery Award 
for ``his outstanding business, civic and philanthropic leadership, and 
for Johnson & Johnson's commitment to the well-being of older adults, 
their families and the communities in which they live.'' The American 
Geriatrics Society is an organization of more than 6,700 health 
professionals devoted to improving the health, independence, and 
quality of life for people as they age. I join them as they honor a 
fellow medical professional for his lifetime of work helping seniors 
and, indeed, people of all ages, live longer, healthier lives.

                          ____________________